Have a question?
Please get in touch with our team in case of any queries
THE GLOBAL SLEEP APNEA DEVICES MARKET SIZE IS EXPECTED TO REACH USD 10 BILLION BY 2027 FROM USD 6.74 BILLION IN 2021, GROWING AT A CAGR OF 7.07% DURING THE FORECAST PERIOD
The Global Sleep Apnea Devices Market Size, Share, & Trends Analysis Report By
- Product: Therapeutic Devices, Facial Interfaces, and Diagnostics Devices
- Age Group: Between 41 & 60 Years, 61 Years & Above, and Below 40 Years
- Gender: Males and Females
- End-User: Sleep Clinics/Labs, Home Healthcare Settings, Hospitals, and Others
- Geography: North America, Europe, APAC, Latin America, and Middle East & Africa
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022–2027
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
SLEEP APNEA DEVICES MARKET REPORT SCOPE
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Market Size (2027) | USD 10.16 Billion |
| Market Size (2021) | USD 6.74 Billion |
| CAGR (2021-2027) | 7.07% |
| Base Year | 2021 |
| Forecast Year | 2022-2027 |
| Market Segments | Product, Age Group, Gender, End-user, and Geography |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| KEY VENDORS | Nihon Kohden Corporation, BMC Medical, Drive DeVilbiss Healthcare, SomnoMed, Glidewell, ResMed, Koninklijke Philips N.V, Fisher & Paykel Healthcare, Compumedics Limited, Inspire Medical Systems, Natus Medical, and Itamar Medical |
The global sleep apnea devices market was valued at USD 6.74 billion in 2021 and is expected to reach USD 10 billion by 2027, growing at a CAGR of 7.07%. The growing sleep apnea devices market is attributed to factors such as the high prevalence of sleep apnea, increasing potential risk factors, technological advancements in sleep apnea devices, and an increasingly aging population. Obstructive sleep apnea (OSA) is particularly prevalent in adults with mild to moderate severity (14% in men and 5% in women) and is becoming more common, partly due to the increasing prevalence of obesity worldwide. The global prevalence of OSA is estimated at 1 billion people, and in some countries, the prevalence in the general population is estimated to exceed 50%.
In developed regions such as North America and Europe, sleep apnea devices are already widely held for OSA. The sleep apnea devices market in these regions is witnessing the entry of many new players and start-ups, promising to provide different products that meet customer demand and market trends. The current trend is smart sleep apnea devices, which are being explored by existing and new players in the market.
The increasing prevalence of obesity and other lifestyle diseases in both developed and developing countries and the rising rate of diagnosis of sleep apnea is presenting a larger patient demographic which requires treatment or management of sleep apnea. This, combined with the increasing number of sleep physicians, technicians, and sleep clinics globally, is facilitating the global sleep apnea devices market's growth.
MARKET TRENDS & OPPORTUNITIES
The Emergence of Artificial Intelligence in Sleep Apnea Treatment
- The convergence of large data sets, increased computing power, and algorithm advances have opened the door to Artificial intelligence (AI) applications across various industries.
- AHI is only a consideration, and the ability to predict side effects and response to treatment is limited. AI offers the opportunity to consider more factors than AHI. AHI provides more information about the severity and OSA endophenotype and can influence treatment choices.
- Artificial intelligence (AI) will pave the way for screening and diagnosing OSA, reduce costly PSG deployment, and streamline the path to effective treatment in the sleep apnea devices market.
Growing Demand and Advancements in Home Sleep Apnea Tests (HSATs)
- In December 2007, the American Academy of Sleep Medicine (AASM) task force published guidelines for the use of unattended wearable monitors (PM) for the diagnosis of obstructive sleep apnea (OSA) in adults. In March 2017, considering recent technological advances in the sleep apnea devices market, the AASM revised its guidelines to include home sleep testing (HST) measuring peripheral arterial tonometry (PAT), oximetry, and actigraphy in obstructive sleep.
- Itamar Medical, a leading player in the sleep apnea diagnostics market, offers WatchPat, the market-leading sleep apnea diagnostic device that uses this proprietary PAT technology.
- ResMed launches a three-part "Onesleeptest" service for NightOwl after acquiring the device’s manufacturer Ectosense. The onesleeptest device accurately tracks and delivers results from a certified sleep specialist within 3-5 business days, making it the ideal solution for testing sleep quality from the comfort and safety of their own home during the pandemic.
Technological Advancements in Continuous Positive Airway Pressure (CPAP) Therapy
- CPAP has changed significantly since its inception in 1981. Devices developed decades ago were heavier, noisier, and had limited performance compared to today's slim, lightweight devices.
- An outstanding innovation is the Automatic Airway Pressure Device (AutoPAP); with AutoPAP, airway pressure begins with light to meet lower pressure needs. When a patient falls asleep, the device automatically adjusts to increase positive airway pressure and keep the respiratory system open. Some CPAP machines in the sleep apnea devices market have the intellectual ability to record the mask on time when the patient breathes into the mask, when the air supply is started and when the mask is removed, and the air stops.
- Another notable feature of CPAP today is its low noise level. In addition to size and weight, the CPAP machine's ability to deliver 20 cm H2O-filtered air to patients with a slight humping is just as refreshing for doctors, patients, and bed partners. The days of sleeping next to mechanically generated hurricanes are over; thanks to a lightweight blower, it is well insulated with CPAP machines.
SEGMENTATION INSIGHTS
PRODUCTS INSIGHTS
The therapeutic devices segment accounts for the highest share of 73.98% in the global sleep apnea devices market by products segment. The therapeutics device segment comprises positive airway pressure (PAP) devices, oral appliances, adaptive servo-ventilators, implants, airway clearance systems, oxygen therapy devices, & accessories. The prevalence of OSA is increasing significantly in developed and developing countries. The prevalence of OSA is rising due to the exponentially growing potential risk factors such as obesity, the aging population, smoking, a sedentary lifestyle, etc. Positive airway pressure (PAP) therapy is a common term used for all sleep apnea treatments that use compressed air flow to support the airways during sleep. The PAP machines continuously witness technological advancements; for instance, these devices combine the variable positive air pressure (VPAP), a relatively new technology, with the automatic adjustments of classic BiPAP therapy's dual-level pressure settings.
The global sleep apnea devices market by facial interfaces was valued at USD 916.7 million in 2021. Continuous positive airway pressure (CPAP) masks and headgear are available in various styles and sizes to help treat sleep apnea. Because everyone's needs, preferences, and face shapes are different, patients may need to try different mask styles before finding the one that works best for them. A mask is used to direct air through the therapy device. Most masks have built-in vents to expel exhaled air.
AGE GROUP INSIGHTS
The global sleep apnea devices market by age group is segmented into between 41 & 60 years, 61 years & above, and below 40 years. Between 41 & 60 years accounted for a larger share, 51.06% in the global market. The 41-60 years of the age group of people are the working adult population facing daily issues from the workplace to the home. The major risk factors for developing OSA and its related symptoms, like snoring in this age group, are work-related stress, alcohol consumption, chronic smoking, and obesity.
GENDER INSIGHTS
The male segment accounted for the highest share of 60.50% in the global sleep apnea devices market by gender segment. OSA is the usual sleep-related breathing disorder, and it is most common in older males. In North America, the estimated prevalence is about 15-30% in males. Most patients with OSA complain of daytime sleepiness or report loud snoring, wheezing, choking, sniffling, or cessation of breathing while their bed partner sleeps. These symptoms are often identified during assessment for another condition, wellness maintenance, or preoperative screening. Women report greater reporting of OSA symptoms for their bed partners. Obesity is a significant risk factor for sleep apnea, and most OSA patients are overweight. Men are more likely than women to increase AHI for a given weight gain, regardless of baseline weight, waist size, age, or race. The global male sleep apnea devices market is expected to grow at a CAGR of 7.30% during the forecast period.
END-USER INSIGHTS
Among all end-users, the sleep clinics/labs segment accounted for the highest share of 39.14% in the global sleep apnea devices market. With the increasing prevalence of sleep disorders, the requirement for sleep labs is also rising. Accurate diagnosis is essential for the determination of sleeping disorders. Because of higher medical accuracy, polysomnography (PSG) is the most preferred technology for diagnosis.
With the increasing incidences of sleeping disorders, the demand for sleep facilities and clinics equipped with technologically advanced PSGs is increasing. Nearly 3,500 sleep labs or clinics have been established across the US since they began in the 1970s. The American Academy of Sleep Medicine has accredited about 1,400 of these facilities. The need for these facilities is supported by research; recent findings relate sleep disturbances to an increased risk of heart attack, stroke, diabetes, rheumatoid arthritis, metabolic disorders, and other illnesses.
GEOGRAPHICAL INSIGHTS
The global sleep apnea devices market is categorized into regions of North America, Europe, APAC, Latin America, and the Middle East & Africa. In 2021, North America dominated the global market and accounted for a revenue share of 40.43%. The region's market growth depends on various factors, including a high prevalence of sleep disorders, a decrease in sleep patterns, lifestyle changes, and the presence of various vendors, including key players, start-ups, and sleep-based companies. The region has witnessed a high prevalence of OSA; for instance, the prevalence of OSA in North America is nearly 15 to 30% in men and 10 to 15% in women. The presence of sleep apnea device manufacturers boosts the region's market share, making it more significant than any other region globally.
Europe's sleep apnea devices market was valued at USD 1.9 billion in 2021. In Europe, the market is driven by the growing use of technology to manage sleep disorders. Technology, such as PAP devices, innovative OAT devices, and diagnostics devices, is getting traction in the European market. APAC proves to be the region with the fastest growth rate among other regions. It is expected to continue its growth during the forecast period and affect the global sleep apnea devices market with its power to manufacture large-scale products. China, Japan, and India are the leading countries in the APAC sleep apnea device, where China is dominating the sleep apnea devices market with its innovative solutions.
VENDOR LANDSCAPE
The global sleep apnea devices market is highly diversified, with several global and local players offering a diverse range of sleep apnea devices such as PAP devices, oral devices, implants, and other devices. The global players focus on developing innovative products and expanding their product portfolio to remain competitive. They are investing extensively in R&D and product development activities to expand their product portfolio. Manufacturers in the global sleep apnea devices market, such as ResMed, Koninklijke Philips N.V, BMC Medical Natus Medical, Itamar Medical, inspire medical system, Compumedics, and Drive DeVilbiss Healthcare, are continuously focusing on product development and offering sophisticated sleep apnea device with new technology to increase their industry presence.
Recent Advancements In The Global Sleep Apnea Devices Market
- In April 2022, Fisher & Paykel Healthcare announced the launch of the F&P Evora Full in the US, a compact full-face mask for OSA.
- In June 2021, Oventus Medical signed a partnership agreement with Aeroflow Healthcare to bring Oventus' OSA treatment solutions, including O2Vent Optima, directly to consumers through US sleep clinics.
- In August 2021, ResMed launched a new PAP device in the US sleep apnea devices market to help hundreds of millions of people with sleep apnea.
- In February 2021, Oventus Medical launched 02Vent Optima, a customizable oral appliance therapy device that offers an alternative to CPAP therapy through GoPAPfree in the US.
- In December 2021, ZOLL Medical Corporation, a subsidiary of Asahi Kasei that manufactures medical devices and related software solutions, announced the acquisition of Itamar Medical Ltd., a medical device and digital health company that provides home testing services.
SNAPSHOT
The sleep apnea devices market is expected to grow at a CAGR of approximately 7.07% from 2022 to 2027.
The following factors are likely to contribute to the growth of the sleep apnea devices market during the forecast period:
- Improvements in Sleep Apnea Diagnosis
- Technological Advancements in Continuous Positive Airway Pressure (CPAP) Therapy
- Increasing Target Patient Population
- High Growth Potential for Upper Airway Stimulation Therapy (Implant) System
Base Year: 2021
Forecast Year: 2022-2027
The report considers the present scenario of the sleep apnea devices market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.
Key Company Profiles
- Nihon Kohden Corporation
- Business Overview
- Product Offerings
- Key Strategies
- Key Strengths
- Key Opportunities
- BMC Medical
- Drive DeVilbiss Healthcare
- SomnoMed
- Glidewell
- ResMed
- Koninklijke Philips N.V
- Fisher & Paykel Healthcare
- Compumedics Limited
- Inspire Medical Systems
- Natus Medical
- Itamar Medical
Other Prominent Vendors
- Apex Medical
- Business Overview
- Product Offerings
- Cadwell Industries
- SOMNOmedics
- Cleveland Medical Devices
- ProSomnus Sleep Technologies
- MEDITAS
- White Dental Healthcare
- Oventus
- Tomed
- Signifier Medical Technologies
- ApneaMed
- Nyxoah
- Vivos Therapeutics
- Somnowell
- RemSleep Holdings
- Siesta Medical
- Horizon Prime
- Nox Medical
- Onera Health
- LivaNova
- ZOLL Medical
- BRAEBON Medical
- Invacare
- Breas Medical
Segmentation by Product:
- Therapeutic Devices
- Facial Interfaces
- Diagnostics Devices
Segmentation by Age Group:
- Between 41 & 60 Years
- 61 Years & Above
- Below 40 Years
Segmentation by Gender:
- Males
- Females
Segmentation by End-User:
- Sleep Clinics/Labs
- Home Healthcare Settings
- Hospitals
- Others
Segmentation by Geography
- North America
- US
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- UK
- APAC
- China
- Japan
- India
- South Korea
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- Turkey
Frequently Asked Questions
How big is the sleep apnea market?
What is the growth rate of the global sleep apnea devices market?
What are the rising trends in the sleep apnea devices market?
Which are the key companies in the global sleep apnea devices market?
Which are the popular CPAP devices available in the market?
Which holds the most significant global sleep apnea devices market share?
LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF GLOBAL SLEEP APNEA DEVICES MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 GLOBAL SLEEP APNEA DEVICES MARKET 2021 & 2027 ($ MILLION)
EXHIBIT 4 GLOBAL SLEEP APNEA DEVICES MARKET SEGMENTATION
EXHIBIT 5 SYMPTOMS OF OSA
EXHIBIT 6 RISK FACTORS FOR SLEEP APNEA
EXHIBIT 7 IMPACT OF IMPLEMENTATION OF AI IN SLEEP APNEA TREATMENTS
EXHIBIT 8 IMPACT OF GROWING DEMAND AND ADVANCES IN HSATS
EXHIBIT 9 THE ADVANTAGES OF TAKING A HOME SLEEP APNEA TEST
EXHIBIT 10 IMPACT OF GROWING ADOPTION OF TELEMEDICINE, MHEALTH IN SLEEP APNEA TREATMENT
EXHIBIT 11 ADVANTAGES OF TELEMEDICINE IN THE MANAGEMENT OF SLEEP APNEA
EXHIBIT 12 TELEHEALTH CONSULTATION SCHEDULED AND COMPLETED BY EMERGING NON-CPAP VENDOR
EXHIBIT 13 IMPACT OF GROWING POPULARITY OF NON-CPAP DEVICES FOR SLEEP APNEA TREATMENT
EXHIBIT 14 PATIENTS STRUGGLE WITH CONVENTIONAL TREATMENT WAYS
EXHIBIT 15 IMPACT OF IMPROVEMENTS IN SLEEP APNEA DIAGNOSIS
EXHIBIT 16 ROLE OF SENSORS & REMOTE MONITORING IN SLEEP APNEA DIAGNOSIS
EXHIBIT 17 IMPACT OF TECHNOLOGICAL ADVANCES IN CPAP THERAPY
EXHIBIT 18 IMPACT OF INCREASING TARGET PATIENT POPULATION
EXHIBIT 19 TYPE 2 DIABETES STATISTICS (MILLION)
EXHIBIT 20 SIGNIFICANT COMORBIDITIES OF CARDIOVASCULAR DISEASES FOR SLEEP APNEA
EXHIBIT 21 IMPACT OF HIGH GROWTH POTENTIAL FOR UPPER AIRWAY STIMULATION THERAPY (IMPLANT) SYSTEM
EXHIBIT 22 IMPACT OF PRESENCE ON NUMEROUS UNDIAGNOSED PATIENTS
EXHIBIT 23 IMPACT OF HIGH COST OF SLEEP APNEA DEVICES
EXHIBIT 24 IMPACT OF AVAILABILITY OF SURGICAL OPTION TO TREAT SLEEP APNEA
EXHIBIT 25 IMPACT OF LACK OF PATIENT ADHERENCE TO CPAP DEVICE
EXHIBIT 26 GLOBAL SLEEP APNEA DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 27 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY: MARKET SHARE 2021 & 2027
EXHIBIT 28 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY: MARKET SHARE 2021 & 2027
EXHIBIT 29 GLOBAL SLEEP APNEA DEVICES MARKET BY AGE GROUP: MARKET SHARE 2021 & 2027
EXHIBIT 30 GLOBAL SLEEP APNEA DEVICES MARKET BY GENDER: MARKET SHARE 2021 & 2027
EXHIBIT 31 GLOBAL SLEEP APNEA DEVICES MARKET BY END-USER: MARKET SHARE 2021 & 2027
EXHIBIT 32 FIVE FORCES ANALYSIS 2021
EXHIBIT 33 INCREMENTAL GROWTH BY PRODUCT SEGMENT 2021 & 2027
EXHIBIT 34 GLOBAL SLEEP APNEA DEVICES MARKET BY PRODUCT
EXHIBIT 35 GLOBAL SLEEP APNEA DEVICES MARKET BY PRODUCT: INCREMENTAL GROWTH
EXHIBIT 36 GLOBAL SLEEP APNEA DEVICE TYPE
EXHIBIT 37 GLOBAL SLEEP APNEA DEVICES MARKET BY PRODUCT: ABSOLUTE GROWTH
EXHIBIT 38 GLOBAL THERAPEUTIC SLEEP APNEA DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 39 SILENT FEATURES OF APAP DEVICE
EXHIBIT 40 TYPES OF MADS
EXHIBIT 41 GLOBAL THERAPEUTIC SLEEP APNEA DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 42 CPAP MASK DESIGN & STRUCTURE
EXHIBIT 43 GLOBAL SLEEP APNEA DEVICES MARKET BY FACIAL INTERFACES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 44 GLOBAL SLEEP APNEA DEVICES MARKET BY FACIAL INTERFACES 2021–2027 ($ MILLION)
EXHIBIT 45 GLOBAL DIAGNOSTICS SLEEP APNEA DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 46 GLOBAL DIAGNOSTICS SLEEP APNEA DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 47 INCREMENTAL GROWTH BY AGE GROUP 2021 & 2027
EXHIBIT 48 GLOBAL SLEEP APNEA DEVICES MARKET BY AGE GROUP
EXHIBIT 49 GLOBAL SLEEP APNEA DEVICES MARKET BY AGE GROUP: INCREMENTAL GROWTH
EXHIBIT 50 GLOBAL SLEEP APNEA DEVICES MARKET BY AGE GROUP: ABSOLUTE GROWTH
EXHIBIT 51 GLOBAL SLEEP APNEA DEVICES MARKET BY BETWEEN 41 & 60 YEARS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 52 GLOBAL SLEEP APNEA DEVICES MARKET BY BETWEEN 41 & 60 YEARS 2021–2027 ($ MILLION)
EXHIBIT 53 GLOBAL SLEEP APNEA DEVICES MARKET BY 61 YEARS & ABOVE: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 54 GLOBAL SLEEP APNEA DEVICES MARKET BY 61 YEARS & ABOVE 2021–2027 ($ MILLION)
EXHIBIT 55 COMMON CAUSE OF OSA IN YOUNG ADULTS 18-40 YEARS OLD
EXHIBIT 56 GLOBAL SLEEP APNEA DEVICES MARKET BY BELOW 40 YEARS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 57 GLOBAL SLEEP APNEA DEVICES MARKET BY BELOW 40 YEARS 2021–2027 ($ MILLION)
EXHIBIT 58 INCREMENTAL GROWTH BY GENDER 2021 & 2027
EXHIBIT 59 GLOBAL SLEEP APNEA DEVICES MARKET BY GENDER
EXHIBIT 60 GLOBAL SLEEP APNEA DEVICES MARKET BY GENDER: INCREMENTAL GROWTH
EXHIBIT 61 GLOBAL SLEEP APNEA DEVICES MARKET BY GENDER: ABSOLUTE GROWTH
EXHIBIT 62 GLOBAL SLEEP APNEA DEVICES MARKET BY MALES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 63 GLOBAL SLEEP APNEA DEVICES MARKET BY MALES 2021–2027 ($ MILLION)
EXHIBIT 64 GLOBAL SLEEP APNEA DEVICES MARKET BY FEMALES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 65 GLOBAL SLEEP APNEA DEVICES MARKET BY FEMALES 2021–2027 ($ MILLION)
EXHIBIT 66 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 67 GLOBAL SLEEP APNEA DEVICES MARKET BY END-USER
EXHIBIT 68 GLOBAL SLEEP APNEA DEVICES MARKET BY END-USER: INCREMENTAL GROWTH
EXHIBIT 69 GLOBAL SLEEP APNEA DEVICES MARKET BY END-USER: ABSOLUTE GROWTH
EXHIBIT 70 GLOBAL SLEEP APNEA DEVICES MARKET BY SLEEP CLINICS/LABS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 71 GLOBAL SLEEP APNEA DEVICES MARKET BY SLEEP CLINICS/LABS 2021–2027 ($ MILLION)
EXHIBIT 72 GLOBAL SLEEP APNEA DEVICES MARKET BY HOME HEALTHCARE SETTINGS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 73 GLOBAL SLEEP APNEA DEVICES MARKET BY HOME HEALTHCARE SETTINGS 2021–2027 ($ MILLION)
EXHIBIT 74 GLOBAL SLEEP APNEA DEVICES MARKET BY HOME HEALTHCARE SETTINGS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 75 GLOBAL SLEEP APNEA DEVICES MARKET BY HOSPITALS 2021–2027 ($ MILLION)
EXHIBIT 76 GLOBAL SLEEP APNEA DEVICES MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 77 GLOBAL SLEEP APNEA DEVICES MARKET BY OTHER END-USERS 2021–2027 ($ MILLION)
EXHIBIT 78 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 79 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY
EXHIBIT 80 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY: KEY COUNTRIES 2021
EXHIBIT 81 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 82 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 83 SLEEP DEPRIVATION STATISTICS OF THE U.S.
EXHIBIT 84 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA: KEY COUNTRIES
EXHIBIT 85 GLOBAL SLEEP APNEA DEVICES MARKET BY NORTH AMERICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 86 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA 2021–2027 ($ MILLION)
EXHIBIT 87 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 88 PREVALENCE & TREATMENT RATE IN US
EXHIBIT 89 US WORK STRESS STATISTICS
EXHIBIT 90 SLEEP APNEA DEVICES MARKET IN US 2021–2027 ($ MILLION)
EXHIBIT 91 CANADIAN HEALTH MEASURES SURVEY (CHMS) 2016-2017
EXHIBIT 92 PREVALENCE OF SLEEP APNEA AMONG ADULTS AGED 18-79 YEARS
EXHIBIT 93 SLEEP APNEA DEVICES MARKET IN CANADA 2021–2027 ($ MILLION)
EXHIBIT 94 SLEEP APNEA DEVICES MARKET IN EUROPE: KEY COUNTRIES
EXHIBIT 95 PREVALENCE OF OSA IN EUROPEAN COUNTRIES IN 2018
EXHIBIT 96 GLOBAL SLEEP APNEA DEVICES MARKET BY EUROPE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 97 SLEEP APNEA DEVICES MARKET IN EUROPE 2021–2027 ($ MILLION)
EXHIBIT 98 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 99 SLEEP APNEA DEVICES MARKET IN GERMANY 2021–2027 ($ MILLION)
EXHIBIT 100 PREVALENCE OF OBESITY AMONG YOUNG PEOPLE BETWEEN 8 AND 17 YEARS
EXHIBIT 101 PREVALENCE OF TREATMENT FOR OSA WITH CPAP
EXHIBIT 102 SLEEP APNEA DEVICES MARKET IN FRANCE 2021–2027 ($ MILLION)
EXHIBIT 103 OSA AND ITS TREATMENT STATISTICS OF UK
EXHIBIT 104 SLEEP APNEA DEVICES MARKET IN UK 2021–2027 ($ MILLION)
EXHIBIT 105 SLEEP APNEA DEVICES MARKET IN ITALY 2021–2027 ($ MILLION)
EXHIBIT 106 SLEEP APNEA DEVICES MARKET IN SPAIN 2021–2027 ($ MILLION)
EXHIBIT 107 SLEEP APNEA DEVICES MARKET IN APAC: KEY COUNTRIES
EXHIBIT 108 SLEEP APNEA DEVICES MARKET IN APAC: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 109 LIST OF THE LEADING SLEEP APNEA DEVICE VENDOR IN APAC
EXHIBIT 110 SLEEP APNEA DEVICE MARKET IN APAC 2021–2027 ($ MILLION)
EXHIBIT 111 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 112 SLEEP APNEA DEVICE MARKET IN CHINA 2021–2027 ($ MILLION)
EXHIBIT 113 SLEEP APNEA DEVICE MARKET IN JAPAN 2021–2027 ($ MILLION)
EXHIBIT 114 SLEEP APNEA DEVICES MARKET IN INDIA 2021–2027 ($ MILLION)
EXHIBIT 115 SLEEP APNEA DEVICE MARKET IN SOUTH KOREA 2021–2027 ($ MILLION)
EXHIBIT 116 SLEEP APNEA STATISTICS IN AUSTRALIA
EXHIBIT 117 SLEEP APNEA DEVICE MARKET IN AUSTRALIA 2021–2027 ($ MILLION)
EXHIBIT 118 SLEEP APNEA DEVICES MARKET IN LATIN AMERICA: KEY COUNTRIES
EXHIBIT 119 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA 2021–2027 ($ MILLION)
EXHIBIT 120 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 121 OSA STATISTICS IN BRAZIL 2016
EXHIBIT 122 OVERWEIGHT & OBESITY STATISTICS BY NATIONAL HEALTH SURVEY 2019
EXHIBIT 123 SLEEP APNEA DEVICE MARKET IN BRAZIL 2021–2027 ($ MILLION)
EXHIBIT 124 SLEEP APNEA DEVICES MARKET IN MEXICO 2021–2027 ($ MILLION)
EXHIBIT 125 SLEEP APNEA DEVICE MARKET IN ARGENTINA 2021–2027 ($ MILLION)
EXHIBIT 126 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA: KEY COUNTRIES
EXHIBIT 127 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 128 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA 2021–2027 ($ MILLION)
EXHIBIT 129 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 130 SLEEP APNEA DEVICE MARKET IN TURKEY 2021–2027 ($ MILLION)
EXHIBIT 131 SLEEP APNEA DEVICE MARKET IN SAUDI ARABIA 2021–2027 ($ MILLION)
EXHIBIT 132 SLEEP APNEA DEVICE MARKET IN SOUTH AFRICA 2021–2027 ($ MILLION)
EXHIBIT 133 GLOBAL SLEEP APNEA DEVICES MARKET: KEY VENDORS CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 134 GLOBAL SLEEP APNEA DEVICES MARKET: KEY VENDORS CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 135 GLOBAL SLEEP APNEA DEVICES MARKET: KEY VENDORS MARKET DOMINANCE ANALYSIS
EXHIBIT 136 GLOBAL SLEEP APNEA DEVICES MARKET: KEY VENDORS MARKET DOMINANCE ANALYSIS
EXHIBIT 137 NIHON KOHDEN CORPORATION: TOTAL REVENUE 2019-2021 ($ MILLION)
EXHIBIT 138 NIHON KOHDEN CORPORATION: REVENUE BY SEGMENT 2021 (%)
EXHIBIT 139 NIHON KOHDEN CORPORATION: REVENUE BY SEGMENT 2021 (% SHARE)
EXHIBIT 140 SOMNOMED: TOTAL REVENUE 2019-2021 ($ MILLION)
EXHIBIT 141 SOMNOMED: REVENUE BY GEOGRAPHY SEGMENT 2021 (%)
EXHIBIT 142 RESMED: TOTAL REVENUE 2020-2022 ($ MILLION)
EXHIBIT 143 RESMED: R&D EXPENSE 2020-2022 ($ MILLION)
EXHIBIT 144 RESMED: TOTAL REVENUE SHARE BY SEGMENT 2022 (%)
EXHIBIT 145 RESMED: REVENUE BY GEOGRAPHY 2022 (%)
EXHIBIT 146 KONINKLIJKE PHILIPS N.V: TOTAL REVENUE 2019-2021 ($ BILLION)
EXHIBIT 147 KONINKLIJKE PHILIPS N.V: R&D EXPENDITURE 2019-2021 ($ MILLION)
EXHIBIT 148 KONINKLIJKE PHILIPS N.V: REVENUE BY BUSINESS SEGMENTS 2021 (%)
EXHIBIT 149 FISHER & PAYKEL HEALTHCARE: TOTAL REVENUE 2020-2022 ($ MILLION)
EXHIBIT 150 FISHER & PAYKEL HEALTHCARE: R&D EXPENDITURE 2020-2022 ($ MILLION)
EXHIBIT 151 FISHER & PAYKEL HEALTHCARE: REVENUE SHARE BY SEGMENT 2022 (%)
EXHIBIT 152 FISHER & PAYKEL HEALTHCARE: REVENUE SHARE BY GEOGRAPHY 2022 (%)
EXHIBIT 153 COMPUMEDICS: TOTAL REVENUE 2020-2022 ($ MILLION)
EXHIBIT 154 COMPUMEDICS: REVENUE SHARE BY GEOGRAPHY 2022 (%)
EXHIBIT 155 INSPIRE MEDICAL SYSTEMS: TOTAL REVENUE 2019-2021 ($ MILLION)
EXHIBIT 156 INSPIRE MEDICAL SYSTEMS: R&D EXPENDITURE 2019-2021 ($ MILLION)
EXHIBIT 157 INSPIRE MEDICAL SYSTEMS: REVENUE SHARE BY GEOGRAPHY 2021 (%)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 POPULAR AVAILABLE CPAP DEVICES
TABLE 4 GLOBAL THERAPEUTIC SLEEP APNEA DEVICES MARKET 2021−2027 ($ MILLION)
TABLE 5 GLOBAL THERAPEUTIC SLEEP APNEA DEVICES MARKET 2021−2027 (%)
TABLE 6 GLOBAL SLEEP APNEA DEVICES MARKET BY FACIAL INTERFACES 2021−2027 ($ MILLION)
TABLE 7 GLOBAL SLEEP APNEA DEVICES MARKET BY FACIAL INTERFACES 2021−2027 (%)
TABLE 8 GLOBAL DIAGNOSTICS SLEEP APNEA DEVICES MARKET 2021−2027 ($ MILLION)
TABLE 9 GLOBAL DIAGNOSTICS SLEEP APNEA DEVICES MARKET 2021−2027 (%)
TABLE 10 GLOBAL SLEEP APNEA DEVICES MARKET BY BETWEEN 41 & 60 YEARS 2021−2027 ($ MILLION)
TABLE 11 GLOBAL SLEEP APNEA DEVICES MARKET BY BETWEEN 41 & 60 YEARS 2021−2027 (%)
TABLE 12 GLOBAL SLEEP APNEA DEVICES MARKET BY 61 YEARS & ABOVE 2021−2027 ($ MILLION)
TABLE 13 GLOBAL SLEEP APNEA DEVICES MARKET BY 61 YEARS & ABOVE 2021−2027 (%)
TABLE 14 GLOBAL SLEEP APNEA DEVICES MARKET BY BELOW 40 YEARS 2021−2027 ($ MILLION)
TABLE 15 GLOBAL SLEEP APNEA DEVICES MARKET BY BELOW 40 YEARS 2021−2027 (%)
TABLE 16 SLEEP DISORDERS AND SYMPTOMS STATISTICS OF THE NORTHWEST ADELAIDE HEALTH STUDY (NWAHS) PARTICIPANTS
TABLE 17 GLOBAL SLEEP APNEA DEVICES MARKET BY MALES 2021−2027 ($ MILLION)
TABLE 18 GLOBAL SLEEP APNEA DEVICES MARKET BY MALES 2021−2027 (%)
TABLE 19 GLOBAL SLEEP APNEA DEVICES MARKET BY FEMALES 2021−2027 ($ MILLION)
TABLE 20 GLOBAL SLEEP APNEA DEVICES MARKET BY FEMALES 2021−2027 (%)
TABLE 21 GLOBAL SLEEP APNEA DEVICES MARKET BY SLEEP CLINICS/LABS 2021−2027 ($ MILLION)
TABLE 22 GLOBAL SLEEP APNEA DEVICES MARKET BY SLEEP CLINICS/LABS 2021−2027 (%)
TABLE 23 GLOBAL SLEEP APNEA DEVICES MARKET BY HOME HEALTHCARE SETTINGS 2021−2027 ($ MILLION)
TABLE 24 GLOBAL SLEEP APNEA DEVICES MARKET BY HOME HEALTHCARE SETTINGS 2021−2027 (%)
TABLE 25 GLOBAL SLEEP APNEA DEVICES MARKET BY HOSPITALS 2021−2027 ($ MILLION)
TABLE 26 GLOBAL SLEEP APNEA DEVICES MARKET BY HOSPITALS 2021−2027 (%)
TABLE 27 GLOBAL SLEEP APNEA DEVICES MARKET BY OTHER END-USERS 2021−2027 ($ MILLION)
TABLE 28 GLOBAL SLEEP APNEA DEVICES MARKET BY OTHER END-USERS 2021−2027 (%)
TABLE 29 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY PRODUCT 2021−2027 ($ MILLION)
TABLE 30 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY PRODUCT 2021−2027 (%)
TABLE 31 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY AGE GROUP 2021−2027 ($ MILLION)
TABLE 32 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY AGE GROUP 2021−2027 (%)
TABLE 33 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY GENDER 2021−2027 ($ MILLION)
TABLE 34 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY GENDER 2021−2027 (%)
TABLE 35 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY END USER 2021−2027 ($ MILLION)
TABLE 36 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY END USER 2021−2027 (%)
TABLE 37 SLEEP APNEA DEVICES MARKET IN EUROPE BY PRODUCT 2021−2027 ($ MILLION)
TABLE 38 SLEEP APNEA DEVICES MARKET IN EUROPE BY PRODUCT 2021−2027 (%)
TABLE 39 SLEEP APNEA DEVICES MARKET IN EUROPE BY AGE GROUP 2021−2027 ($ MILLION)
TABLE 40 SLEEP APNEA DEVICES MARKET IN EUROPE BY 2021−2027 (%)
TABLE 41 SLEEP APNEA DEVICES MARKET IN EUROPE BY GENDER 2021−2027 ($ MILLION)
TABLE 42 SLEEP APNEA DEVICES MARKET IN EUROPE BY GENDER 2021−2027 (%)
TABLE 43 SLEEP APNEA DEVICES MARKET IN EUROPE BY END USER 2021−2027 ($ MILLION)
TABLE 44 SLEEP APNEA DEVICES MARKET IN EUROPE BY END USER 2021−2027 (%)
TABLE 45 SLEEP APNEA DEVICE MARKET IN APAC BY PRODUCT 2021−2027 ($ MILLION)
TABLE 46 SLEEP APNEA DEVICE MARKET IN APAC BY PRODUCT 2021−2027 (%)
TABLE 47 SLEEP APNEA DEVICE MARKET IN APAC BY AGE GROUP 2021−2027 ($ MILLION)
TABLE 48 SLEEP APNEA DEVICE MARKET IN APAC BY AGE GROUP 2021−2027 (%)
TABLE 49 SLEEP APNEA DEVICE MARKET IN APAC BY GENDER 2021−2027 ($ MILLION)
TABLE 50 SLEEP APNEA DEVICE MARKET IN APAC BY GENDER 2021−2027 (%)
TABLE 51 SLEEP APNEA DEVICE MARKET IN APAC BY END USER 2021−2027 ($ MILLION)
TABLE 52 SLEEP APNEA DEVICE MARKET IN APAC BY END USER 2021−2027 (%)
TABLE 53 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY PRODUCT 2021−2027 ($ MILLION)
TABLE 54 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY PRODUCT 2021−2027 (%)
TABLE 55 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY AGE GROUP 2021−2027 ($ MILLION)
TABLE 56 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY 2021−2027 (%)
TABLE 57 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY GENDER 2021−2027 ($ MILLION)
TABLE 58 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY GENDER 2021−2027 (%)
TABLE 59 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY END USER 2021−2027 ($ MILLION)
TABLE 60 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY END USER 2021−2027 (%)
TABLE 61 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY PRODUCT 2021−2027 ($ MILLION)
TABLE 62 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY PRODUCT 2021−2027 (%)
TABLE 63 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY AGE GROUP 2021−2027 ($ MILLION)
TABLE 64 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY 2021−2027 (%)
TABLE 65 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY GENDER 2021−2027 ($ MILLION)
TABLE 66 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY GENDER 2021−2027 (%)
TABLE 67 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY END USER 2021−2027 ($ MILLION)
TABLE 68 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY END USER 2021−2027 (%)
TABLE 69 LEADING VENDORS BASED ON SLEEP APNEA PRODUCT PORTFOLIO
TABLE 70 NIHON KOHDEN CORPORATION: MAJOR PRODUCT OFFERINGS
TABLE 71 BMC MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 72 DRIVE DEVILBISS HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 73 SOMNOMED: MAJOR PRODUCT OFFERINGS
TABLE 74 GLIDEWELL: MAJOR PRODUCT OFFERINGS
TABLE 75 RESMED: MAJOR PRODUCT OFFERINGS
TABLE 76 KONINKLIJKE PHILIPS N.V: MAJOR PRODUCT OFFERINGS
TABLE 77 FISHER & PAYKEL HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 78 COMPUMEDICS: MAJOR PRODUCT OFFERINGS
TABLE 79 INSPIRE MEDICAL SYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 80 NATUS MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 81 ITAMAR MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 82 APEX MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 83 CADWELL INDUSTRIES: MAJOR PRODUCT OFFERINGS
TABLE 84 SOMNOMEDICS: MAJOR PRODUCT OFFERINGS
TABLE 85 CLEVELAND MEDICAL DEVICES: MAJOR PRODUCT OFFERINGS
TABLE 86 PROSOMNUS SLEEP TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 87 MEDITAS: MAJOR PRODUCT OFFERINGS
TABLE 88 WHITE DENTAL HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 89 OVENTUS: MAJOR PRODUCT OFFERINGS
TABLE 90 TOMED: MAJOR PRODUCT OFFERINGS
TABLE 91 SIGNIFIER MEDICAL TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 92 APNEAMED: MAJOR PRODUCT OFFERINGS
TABLE 93 NYXOAH: MAJOR PRODUCT OFFERINGS
TABLE 94 VIVOS THERAPEUTICS: MAJOR PRODUCT OFFERINGS
TABLE 95 SOMNOWELL: MAJOR PRODUCT OFFERINGS
TABLE 96 REMSLEEP HOLDINGS: MAJOR PRODUCT OFFERINGS
TABLE 97 SIESTA MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 98 HORIZON PRIME: MAJOR PRODUCT OFFERINGS
TABLE 99 NOX MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 100 ONERA HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 101 LIVANOVA: MAJOR PRODUCT OFFERINGS
TABLE 102 ZOLL MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 103 BRAEBON MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 104 INVACARE: MAJOR PRODUCT OFFERINGS
TABLE 105 BREAS MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 106 GLOBAL SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 ($ MILLION)
TABLE 107 GLOBAL SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 (%)
TABLE 108 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 ($ MILLION)
TABLE 109 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 (%)
TABLE 110 EUROPE SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 ($ MILLION)
TABLE 111 EUROPE SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 (%)
TABLE 112 APAC SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 ($ MILLION)
TABLE 113 APAC SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 (%)
TABLE 114 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 ($ MILLION)
TABLE 115 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 (%)
TABLE 116 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 ($ MILLION)
TABLE 117 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY PRODUCT 2021−2027 (%)
TABLE 118 GLOBAL SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 ($ MILLION)
TABLE 119 GLOBAL SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 (%)
TABLE 120 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 ($ MILLION)
TABLE 121 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 (%)
TABLE 122 EUROPE SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 ($ MILLION)
TABLE 123 EUROPE SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 (%)
TABLE 124 APAC SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 ($ MILLION)
TABLE 125 APAC SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 (%)
TABLE 126 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 ($ MILLION)
TABLE 127 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 (%)
TABLE 128 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 ($ MILLION)
TABLE 129 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021−2027 (%)
TABLE 130 GLOBAL SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 ($ MILLION)
TABLE 131 GLOBAL SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 (%)
TABLE 132 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 ($ MILLION)
TABLE 133 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 (%)
TABLE 134 EUROPE SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 ($ MILLION)
TABLE 135 EUROPE SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 (%)
TABLE 136 APAC SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 ($ MILLION)
TABLE 137 APAC SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 (%)
TABLE 138 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 ($ MILLION)
TABLE 139 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 (%)
TABLE 140 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 ($ MILLION)
TABLE 141 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY GENDER 2021−2027 (%)
TABLE 142 GLOBAL SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 ($ MILLION)
TABLE 143 GLOBAL SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 (%)
TABLE 144 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 ($ MILLION)
TABLE 145 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 (%)
TABLE 146 EUROPE SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 ($ MILLION)
TABLE 147 EUROPE SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 (%)
TABLE 148 APAC SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 ($ MILLION)
TABLE 149 APAC SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 (%)
TABLE 150 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 ($ MILLION)
TABLE 151 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 (%)
TABLE 152 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 ($ MILLION)
TABLE 153 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY END-USER 2021−2027 (%)
TABLE 154 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 155 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 156 GLOBAL THERAPEUTIC SLEEP APNEA DEVICES MARKET 2021−2027 ($ MILLION)
TABLE 157 GLOBAL THERAPEUTIC SLEEP APNEA DEVICES MARKET 2021−2027 (%)
TABLE 158 GLOBAL SLEEP APNEA DEVICES MARKET BY FACIAL INTERFACES 2021−2027 ($ MILLION)
TABLE 159 GLOBAL SLEEP APNEA DEVICES MARKET BY FACIAL INTERFACES 2021−2027 (%)
TABLE 160 GLOBAL DIAGNOSTIC SLEEP APNEA DEVICES MARKET 2021−2027 ($ MILLION)
TABLE 161 GLOBAL DIAGNOSTIC SLEEP APNEA DEVICES MARKET 2021−2027 (%)
TABLE 162 GLOBAL SLEEP APNEA DEVICES MARKET BY BETWEEN 41 & 60 YEARS 2021−2027 ($ MILLION)
TABLE 163 GLOBAL SLEEP APNEA DEVICES MARKET BY BETWEEN 41 & 60 YEARS 2021−2027 (%)
TABLE 164 GLOBAL SLEEP APNEA DEVICES MARKET BY 61 YEARS & ABOVE 2021−2027 ($ MILLION)
TABLE 165 GLOBAL SLEEP APNEA DEVICES MARKET BY 61 YEARS & ABOVE 2021−2027 (%)
TABLE 166 GLOBAL SLEEP APNEA DEVICES MARKET BY BELOW 40 YEARS 2021−2027 ($ MILLION)
TABLE 167 GLOBAL SLEEP APNEA DEVICES MARKET BY BELOW 40 YEARS 2021−2027 (%)
TABLE 168 GLOBAL SLEEP APNEA DEVICES MARKET BY MALES 2021−2027 ($ MILLION)
TABLE 169 GLOBAL SLEEP APNEA DEVICES MARKET BY MALES 2021−2027 (%)
TABLE 170 GLOBAL SLEEP APNEA DEVICES MARKET BY FEMALES 2021−2027 ($ MILLION)
TABLE 171 GLOBAL SLEEP APNEA DEVICES MARKET BY FEMALES 2021−2027 (%)
TABLE 172 GLOBAL SLEEP APNEA DEVICES MARKET BY SLEEP CLINICS/LABS 2021−2027 ($ MILLION)
TABLE 173 GLOBAL SLEEP APNEA DEVICES MARKET BY SLEEP CLINICS/LABS 2021−2027 (%)
TABLE 174 GLOBAL SLEEP APNEA DEVICES MARKET BY HOME HEALTHCARE SETTINGS 2021−2027 ($ MILLION)
TABLE 175 GLOBAL SLEEP APNEA DEVICES MARKET BY HOME HEALTHCARE SETTINGS 2021−2027 (%)
TABLE 176 GLOBAL SLEEP APNEA DEVICES MARKET BY HOSPITALS 2021−2027 ($ MILLION)
TABLE 177 GLOBAL SLEEP APNEA DEVICES MARKET BY HOSPITALS 2021−2027 (%)
TABLE 178 GLOBAL SLEEP APNEA DEVICES MARKET BY OTHER END-USERS 2021−2027 ($ MILLION)
TABLE 179 GLOBAL SLEEP APNEA DEVICES MARKET BY OTHER END-USERS 2021−2027 (%)
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 PREMIUM INSIGHTS
7.1 MARKET OVERVIEW
7.1.1 MARKET DYNAMICS
7.1.2 MARKET SEGMENTATION
7.1.3 VENDOR ANALYSIS
7.1.4 RECENT ADVANCES
8 INTRODUCTION
8.1 OVERVIEW
8.1.1 RISK FACTORS
8.1.2 DIAGNOSIS OF SLEEP APNEA
8.1.3 TREATMENT FOR SLEEP APNEA
9 MARKET OPPORTUNITIES & TRENDS
9.1 IMPLEMENTATION OF AI IN SLEEP APNEA TREATMENTS
9.2 GROWING DEMAND AND ADVANCES IN HOME SLEEP APNEA TESTS (HSATS)
9.3 GROWING ADOPTION OF TELEMEDICINE, MHEALTH IN SLEEP APNEA TREATMENT
9.4 GROWING POPULARITY OF NON-CPAP DEVICES FOR SLEEP APNEA TREATMENT
10 MARKET GROWTH ENABLERS
10.1 IMPROVEMENTS IN SLEEP APNEA DIAGNOSIS
10.2 TECHNOLOGICAL ADVANCES IN CPAP THERAPY
10.3 INCREASING TARGET PATIENT POPULATION
10.4 HIGH GROWTH POTENTIAL FOR UPPER AIRWAY STIMULATION THERAPY (IMPLANT) SYSTEM
11 MARKET RESTRAINTS
11.1 PRESENCE OF NUMEROUS UNDIAGNOSED PATIENTS
11.2 HIGH COST OF SLEEP APNEA DEVICES
11.3 AVAILABILITY OF SURGICAL OPTION TO TREAT SLEEP APNEA
11.4 LACK OF PATIENT ADHERENCE TO CPAP DEVICE
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 INSIGHTS BY GEOGRAPHY SEGMENTATION
12.2.2 INSIGHTS BY PRODUCT SEGMENTATION
12.2.3 INSIGHTS BY AGE GROUP SEGMENTATION
12.2.4 INSIGHTS BY GENDER SEGMENTATION
12.2.5 INSIGHTS BY END-USER SEGMENTATION
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 PRODUCT
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 THERAPEUTIC DEVICES
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 FACIAL INTERFACES
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
13.5 DIAGNOSTICS DEVICES
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MARKET BY GEOGRAPHY
14 AGE GROUP
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 BETWEEN 41 & 60 YEARS
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 61 YEARS & ABOVE
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 BELOW 40 YEARS
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY
15 GENDER
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 MALES
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 FEMALES
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
16 END-USER
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 SLEEP CLINICS/LABS
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 MARKET BY GEOGRAPHY
16.4 HOME HEALTHCARE SETTINGS
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.4.3 MARKET BY GEOGRAPHY
16.5 HOSPITALS
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.5.3 MARKET BY GEOGRAPHY
16.6 OTHERS
16.6.1 MARKET OVERVIEW
16.6.2 MARKET SIZE & FORECAST
16.6.3 MARKET BY GEOGRAPHY
17 GEOGRAPHY
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 GEOGRAPHIC OVERVIEW
18 NORTH AMERICA
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.2.1 NORTH AMERICA: PRODUCT SEGMENTATION
18.2.2 NORTH AMERICA: AGE GROUP SEGMENTATION
18.2.3 NORTH AMERICA: GENDER SEGMENTATION
18.2.4 NORTH AMERICA: END USER SEGMENTATION
18.3 KEY COUNTRIES
18.3.1 US: MARKET SIZE & FORECAST
18.3.2 CANADA: MARKET SIZE & FORECAST
19 EUROPE
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.2.1 EUROPE: PRODUCT SEGMENTATION
19.2.2 EUROPE: AGE GROUP SEGMENTATION
19.2.3 EUROPE: GENDER SEGMENTATION
19.2.4 EUROPE: END USER SEGMENTATION
19.3 KEY COUNTRIES
19.3.1 GERMANY: MARKET SIZE & FORECAST
19.3.2 FRANCE: MARKET SIZE & FORECAST
19.3.3 UK: MARKET SIZE & FORECAST
19.3.4 ITALY: MARKET SIZE & FORECAST
19.3.5 SPAIN: MARKET SIZE & FORECAST
20 APAC
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.2.1 APAC: PRODUCT SEGMENTATION
20.2.2 APAC: AGE GROUP SEGMENTATION
20.2.3 APAC: GENDER SEGMENTATION
20.2.4 APAC: END USER SEGMENTATION
20.3 KEY COUNTRIES
20.3.1 CHINA: MARKET SIZE & FORECAST
20.3.2 JAPAN: MARKET SIZE & FORECAST
20.3.3 INDIA: MARKET SIZE & FORECAST
20.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
20.3.5 AUSTRALIA: MARKET SIZE & FORECAST
21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.2.1 LATIN AMERICA: PRODUCT SEGMENTATION
21.2.2 LATIN AMERICA: AGE GROUP SEGMENTATION
21.2.3 LATIN AMERICA: GENDER SEGMENTATION
21.2.4 LATIN AMERICA: END USER SEGMENTATION
21.3 KEY COUNTRIES
21.3.1 BRAZIL: MARKET SIZE & FORECAST
21.3.2 MEXICO: MARKET SIZE & FORECAST
21.3.3 ARGENTINA: MARKET SIZE & FORECAST
22 MIDDLE EAST & AFRICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.2.1 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
22.2.2 MIDDLE EAST & AFRICA: AGE GROUP SEGMENTATION
22.2.3 MIDDLE EAST & AFRICA: GENDER SEGMENTATION
22.2.4 MIDDLE EAST & AFRICA: END USER SEGMENTATION
22.3 KEY COUNTRIES
22.3.1 TURKEY: MARKET SIZE & FORECAST
22.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
22.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST
23 COMPETITIVE LANDSCAPE
23.1 COMPETITION OVERVIEW
23.2 MARKET SHARE ANALYSIS
24 KEY COMPANY PROFILES
24.1 NIHON KOHDEN CORPORATION
24.1.1 BUSINESS OVERVIEW
24.1.2 NIHON KOHDEN CORPORATION IN SLEEP APNEA MARKET
24.1.3 PRODUCT OFFERINGS
24.1.4 KEY STRATEGIES
24.1.5 KEY STRENGTHS
24.1.6 KEY OPPORTUNITIES
24.2 BMC MEDICAL
24.2.1 BUSINESS OVERVIEW
24.2.2 BMC MEDICAL IN SLEEP APNEA MARKET
24.2.3 PRODUCT OFFERINGS
24.2.4 KEY STRATEGIES
24.2.5 KEY STRENGTHS
24.2.6 KEY OPPORTUNITIES
24.3 DRIVE DEVILBISS HEALTHCARE
24.3.1 BUSINESS OVERVIEW
24.3.2 DRIVE DEVILBISS HEALTHCARE IN SLEEP APNEA MARKET
24.3.3 PRODUCT OFFERINGS
24.3.4 KEY STRATEGIES
24.3.5 KEY STRENGTHS
24.3.6 KEY OPPORTUNITIES
24.4 SOMNOMED
24.4.1 BUSINESS OVERVIEW
24.4.2 SOMNOMED IN SLEEP APNEA MARKET
24.4.3 PRODUCT OFFERINGS
24.4.4 KEY STRATEGIES
24.4.5 KEY STRENGTHS
24.4.6 KEY OPPORTUNITIES
24.5 GLIDEWELL
24.5.1 BUSINESS OVERVIEW
24.5.2 GLIDEWELL IN SLEEP APNEA MARKET
24.5.3 PRODUCT OFFERINGS
24.5.4 KEY STRATEGIES
24.5.5 KEY STRENGTHS
24.5.6 KEY OPPORTUNITIES
24.6 RESMED
24.6.1 BUSINESS OVERVIEW
24.6.2 RESMED IN SLEEP APNEA MARKET
24.6.3 PRODUCT OFFERINGS
24.6.4 KEY STRATEGIES
24.6.5 KEY STRENGTHS
24.6.6 KEY OPPORTUNITIES
24.7 KONINKLIJKE PHILIPS N.V
24.7.1 BUSINESS OVERVIEW
24.7.2 KONINKLIJKE PHILIPS N.V IN SLEEP APNEA MARKET
24.7.3 PRODUCT OFFERINGS
24.7.4 KEY STRATEGIES
24.7.5 KEY STRENGTHS
24.7.6 KEY OPPORTUNITIES
24.8 FISHER & PAYKEL HEALTHCARE
24.8.1 BUSINESS OVERVIEW
24.8.2 FISHER & PAYKEL HEALTHCARE IN SLEEP APNEA MARKET
24.8.3 PRODUCT OFFERINGS
24.8.4 KEY STRATEGIES
24.8.5 KEY STRENGTHS
24.8.6 KEY OPPORTUNITIES
24.9 COMPUMEDICS LIMITED
24.9.1 BUSINESS OVERVIEW
24.9.2 COMPUMEDICS IN SLEEP APNEA MARKET
24.9.3 PRODUCT OFFERINGS
24.9.4 KEY STRATEGIES
24.9.5 KEY STRENGTHS
24.9.6 KEY OPPORTUNITIES
24.10 INSPIRE MEDICAL SYSTEMS
24.10.1 BUSINESS OVERVIEW
24.10.2 INSPIRE MEDICAL SYSTEMS IN SLEEP APNEA MARKET
24.10.3 PRODUCT OFFERINGS
24.10.4 KEY STRATEGIES
24.10.5 KEY STRENGTHS
24.10.6 KEY OPPORTUNITIES
24.11 NATUS MEDICAL
24.11.1 BUSINESS OVERVIEW
24.11.2 NATUS MEDICAL IN SLEEP APNEA MARKET
24.11.3 PRODUCT OFFERINGS
24.11.4 KEY STRATEGIES
24.11.5 KEY STRENGTHS
24.11.6 KEY OPPORTUNITIES
24.12 ITAMAR MEDICAL
24.12.1 BUSINESS OVERVIEW
24.12.2 ITAMAR MEDICAL IN SLEEP APNEA DEVICES MARKET
24.12.3 PRODUCT OFFERINGS
24.12.4 KEY STRATEGIES
24.12.5 KEY STRENGTHS
24.12.6 KEY OPPORTUNITIES
25 OTHER PROMINENT VENDORS
25.1 APEX MEDICAL
25.1.1 BUSINESS OVERVIEW
25.1.2 PRODUCT OFFERINGS
25.2 CADWELL INDUSTRIES
25.2.1 BUSINESS OVERVIEW
25.2.2 PRODUCT OFFERINGS
25.3 SOMNOMEDICS
25.3.1 BUSINESS OVERVIEW
25.3.2 PRODUCT OFFERINGS
25.4 CLEVELAND MEDICAL DEVICES
25.4.1 BUSINESS OVERVIEW
25.4.2 PRODUCT OFFERINGS
25.5 PROSOMNUS SLEEP TECHNOLOGIES
25.5.1 BUSINESS OVERVIEW
25.5.2 PRODUCT OFFERINGS
25.6 MEDITAS
25.6.1 BUSINESS OVERVIEW
25.6.2 PRODUCT OFFERINGS
25.7 WHITE DENTAL HEALTHCARE
25.7.1 BUSINESS OVERVIEW
25.7.2 PRODUCT OFFERINGS
25.8 OVENTUS
25.8.1 BUSINESS OVERVIEW
25.8.2 PRODUCT OFFERINGS
25.9 TOMED
25.9.1 BUSINESS OVERVIEW
25.9.2 PRODUCT OFFERINGS
25.10 SIGNIFIER MEDICAL TECHNOLOGIES
25.10.1 BUSINESS OVERVIEW
25.10.2 PRODUCT OFFERINGS
25.11 APNEAMED
25.11.1 BUSINESS OVERVIEW
25.11.2 PRODUCT OFFERINGS
25.12 NYXOAH
25.12.1 BUSINESS OVERVIEW
25.12.2 PRODUCT OFFERINGS
25.13 VIVOS THERAPEUTICS
25.13.1 BUSINESS OVERVIEW
25.13.2 PRODUCT OFFERINGS
25.14 SOMNOWELL
25.14.1 BUSINESS OVERVIEW
25.14.2 PRODUCT OFFERINGS
25.15 REMSLEEP HOLDINGS
25.15.1 BUSINESS OVERVIEW
25.15.2 PRODUCT OFFERINGS
25.16 SIESTA MEDICAL
25.16.1 BUSINESS OVERVIEW
25.16.2 PRODUCT OFFERINGS
25.17 HORIZON PRIME
25.17.1 BUSINESS OVERVIEW
25.17.2 PRODUCT OFFERINGS
25.18 NOX MEDICAL
25.18.1 BUSINESS OVERVIEW
25.18.2 PRODUCT OFFERINGS
25.19 ONERA HEALTH
25.19.1 BUSINESS OVERVIEW
25.19.2 PRODUCT OFFERINGS
25.20 LIVANOVA
25.20.1 BUSINESS OVERVIEW
25.20.2 PRODUCT OFFERINGS
25.21 ZOLL MEDICAL
25.21.1 BUSINESS OVERVIEW
25.21.2 PRODUCT OFFERINGS
25.22 BRAEBON MEDICAL
25.22.1 BUSINESS OVERVIEW
25.22.2 PRODUCT OFFERINGS
25.23 INVACARE
25.23.1 BUSINESS OVERVIEW
25.23.2 PRODUCT OFFERINGS
25.24 BREAS MEDICAL
25.24.1 BUSINESS OVERVIEW
25.24.2 PRODUCT OFFERINGS
26 REPORT SUMMARY
26.1 KEY TAKEAWAYS
26.2 STRATEGIC RECOMMENDATIONS.
27 QUANTITATIVE SUMMARY
27.1 MARKET BY PRODUCT
27.1.1 NORTH AMERICA: PRODUCT SEGMENTATION
27.1.2 EUROPE: PRODUCT SEGMENTATION
27.1.3 APAC: PRODUCT SEGMENTATION
27.1.4 LATIN AMERICA: PRODUCT SEGMENTATION
27.1.5 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
27.2 MARKET BY AGE GROUP
27.2.1 NORTH AMERICA: AGE GROUP SEGMENTATION
27.2.2 EUROPE: AGE GROUP SEGMENTATION
27.2.3 APAC: AGE GROUP SEGMENTATION
27.2.4 LATIN AMERICA: AGE GROUP SEGMENTATION
27.2.5 MIDDLE EAST & AFRICA: AGE GROUP SEGMENTATION
27.3 MARKET BY GENDER
27.3.1 NORTH AMERICA: GENDER SEGMENTATION
27.3.2 EUROPE: GENDER SEGMENTATION
27.3.3 APAC: GENDER SEGMENTATION
27.3.4 LATIN AMERICA: GENDER SEGMENTATION
27.3.5 MIDDLE EAST & AFRICA: GENDER SEGMENTATION
27.4 MARKET BY END USER
27.4.1 NORTH AMERICA: END USER SEGMENTATION
27.4.2 EUROPE: END USER SEGMENTATION
27.4.3 APAC: END USER SEGMENTATION
27.4.4 LATIN AMERICA: END USER SEGMENTATION
27.4.5 MIDDLE EAST & AFRICA: END USER SEGMENTATION
27.5 MARKET BY GEOGRAPHY
27.5.1 THERAPEUTIC DEVICES: GEOGRAPHY SEGMENTATION
27.5.2 FACIAL INTERFACES: GEOGRAPHY SEGMENTATION
27.5.3 DIAGNOSTICS DEVICE: GEOGRAPHY SEGMENTATION
27.5.4 BETWEEN 41 & 60 YEARS: GEOGRAPHY SEGMENTATION
27.5.5 61 YEARS & ABOVE: GEOGRAPHY SEGMENTATION
27.5.6 BELOW 40 YEARS: GEOGRAPHY SEGMENTATION
27.5.7 MALES: GEOGRAPHY SEGMENTATION
27.5.8 FEMALES: GEOGRAPHY SEGMENTATION
27.5.9 SLEEP CLINICS/LABS: GEOGRAPHY SEGMENTATION
27.5.10 HOME HEALTHCARE SETTINGS: GEOGRAPHY SEGMENTATION
27.5.11 HOSPITALS: GEOGRAPHY SEGMENTATION
27.5.12 OTHERS: GEOGRAPHY SEGMENTATION
28 APPENDIX
28.1 ABBREVIATIONS
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
How big is the sleep apnea market?
What is the growth rate of the global sleep apnea devices market?
What are the rising trends in the sleep apnea devices market?
Which are the key companies in the global sleep apnea devices market?
Which are the popular CPAP devices available in the market?
Which holds the most significant global sleep apnea devices market share?
Other RELATED Reports
U.S. Sleep Disorder Clinics Market – Industry Outlook & Forecast 2022-2027
Published : October 2022
Anti-Snoring Devices Market - Global Outlook & Forecast 2022-2027
Published : November 2022